Howard Kim

About the Author Howard Kim


Wall Street Analysts Are Bullish on Top Technology Picks

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Varonis Systems (VRNS), Cisco Systems …

Canaccord Genuity’s Take on This Canadian Energy Stock

Canaccord Genuity analyst Anthony Petrucci maintained a Buy rating on Tamarack Valley Energy (TNEYF) yesterday and set a price target of C$1.20.

JonesTrading Believes Trillium Therapeutics (TRIL) Won’t Stop Here

In a report released yesterday, Soumit Roy from JonesTrading reiterated a Buy rating on Trillium Therapeutics (TRIL), with a price target of $15.00.

Canaccord Genuity Maintains a Buy Rating on TELA Bio (TELA)

Canaccord Genuity analyst Kyle Rose maintained a Buy rating on TELA Bio (TELA) yesterday and set a price target of $18.00.

Analysts Offer Insights on Healthcare Companies: Cortexyme (CRTX) and ConforMIS (CFMS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cortexyme (CRTX) and ConforMIS (CFMS) …

Santander Consumer USA (SC) Gets a Buy Rating from Jefferies

Jefferies analyst John Hecht assigned a Buy rating to Santander Consumer USA (SC) on July 29 and set a price target of $22.00.

Analysts Offer Insights on Utilities Companies: Antero Resources (AR) and Western Midstream Partners (WES)

There’s a lot to be optimistic about in the Utilities sector as 2 analysts just weighed in on Antero Resources (AR) and Western …

What Made Oppenheimer Upgrade The Estée Lauder Companies’ Stock?

The Estée Lauder Companies (EL) received a Buy rating and a $240.00 price target from Oppenheimer analyst Rupesh Parikh today.

1Life Healthcare (ONEM) Gets a Hold Rating from Wells Fargo

In a report released yesterday, Jamie Stockton from Wells Fargo maintained a Hold rating on 1Life Healthcare (ONEM). The company’s shares closed last …

Oppenheimer Sticks to Their Buy Rating for Frequency Therapeutics (FREQ)

Oppenheimer analyst Jay Olson maintained a Buy rating on Frequency Therapeutics (FREQ) yesterday and set a price target of $36.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts